Thomas J. Scriba mostly deals with Tuberculosis, Immunology, Mycobacterium tuberculosis, Vaccination and Tuberculosis vaccines. Thomas J. Scriba works on Tuberculosis which deals in particular with BCG vaccine. His studies examine the connections between Immunology and genetics, as well as such issues in Virology, with regards to Immunity.
His biological study spans a wide range of topics, including Seroconversion, Antigen and Cohort. His Vaccination study combines topics in areas such as Inflammation and Myeloid. His study explores the link between Tuberculosis vaccines and topics such as Clinical trial that cross with problems in Adverse effect.
Thomas J. Scriba mainly investigates Tuberculosis, Immunology, Mycobacterium tuberculosis, Immune system and Vaccination. Thomas J. Scriba has researched Tuberculosis in several fields, including Internal medicine, Disease and Cohort. His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell and Virology.
His studies in Mycobacterium tuberculosis integrate themes in fields like Innate immune system, Immunopathology and Immunity. He has included themes like Tumor necrosis factor alpha, Whole blood and Cytokine in his Immune system study. Thomas J. Scriba has included themes like Adverse effect and Randomized controlled trial in his Vaccination study.
His primary scientific interests are in Tuberculosis, Immunology, Mycobacterium tuberculosis, Immune system and Disease. His biological study spans a wide range of topics, including MEDLINE, Environmental health, Immunopathology, Biomarker and Cohort. His research on Immunology frequently connects to adjacent areas such as Respiratory tract.
His Mycobacterium tuberculosis research includes elements of Chemokine, T cell, Area under the curve and Antigen. His Immune system study also includes fields such as
Thomas J. Scriba mainly focuses on Mycobacterium tuberculosis, Tuberculosis, Immunology, Immune system and Disease. His work in Mycobacterium tuberculosis is not limited to one particular discipline; it also encompasses Genome. His work carried out in the field of Tuberculosis brings together such families of science as Biomarker and Immunopathology.
His Immunology study focuses on Vaccination in particular. His Immune system research is multidisciplinary, relying on both Tumor necrosis factor alpha, Gene and Antigen. His Disease research is multidisciplinary, incorporating elements of Oncology, Venous blood, Positron emission tomography, Subclinical infection and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
Michele D Tameris;Mark Hatherill;Bernard S Landry;Thomas J Scriba.
The Lancet (2013)
Immunological biomarkers of tuberculosis.
Gerhard Walzl;Katharina Ronacher;Willem Hanekom;Thomas J. Scriba.
Nature Reviews Immunology (2011)
Distinct, Specific IL-17- and IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response
Thomas J. Scriba;Barbara Kalsdorf;Deborah-Ann Abrahams;Fatima Isaacs.
Journal of Immunology (2008)
Identifying specificity groups in the T cell receptor repertoire
Jacob Glanville;Huang Huang;Allison Nau;Olivia Hatton.
A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
Daniel E Zak;Adam Penn-Nicholson;Thomas J Scriba;Ethan Thompson.
The Lancet (2016)
Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns
Benjamin M. N. Kagina;Brian Abel;Thomas J. Scriba;Elizabeth J. Hughes.
American Journal of Respiratory and Critical Care Medicine (2010)
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
Elisa Nemes;Hennie Geldenhuys;Virginie Rozot;Kathryn T Rutkowski.
The New England Journal of Medicine (2018)
Bacillus Calmette-Guérin Vaccination of Human Newborns Induces T Cells with Complex Cytokine and Phenotypic Profiles
Andreia P. Soares;Thomas J. Scriba;Sarah Joseph;Ryhor Harbacheuski.
Journal of Immunology (2008)
T cells and adaptive immunity to Mycobacterium tuberculosis in humans
Luke D. Jasenosky;Thomas J. Scriba;Willem A. Hanekom;Willem A. Hanekom;Anne E. Goldfeld.
Immunological Reviews (2015)
Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells
Thomas J. Scriba;Michele Tameris;Nazma Mansoor;Erica Smit.
European Journal of Immunology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: